Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

In hepatocellular carcinoma, also known as liver cancer, patients were found to respond to presurgical treatment with immune ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Researchers conducted a nationwide cohort study using data from the Taiwan National Health Insurance database and the Taiwan ...

Checkpoint inhibitors are a novel breakthrough that unleash the immune system’s natural cancer-fighting abilities—mainly surveilling the body and eliminating any cancer cells it finds.

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis.

Source: Getty Images Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say. The most common immune-related ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but many patients with metastatic cancer develop resistance. Understanding the mechanisms behind this resistance is ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

Researchers at the University of Michigan Rogel Cancer Center have discovered a key reason why some cancers do not respond to ...

"But those rules just don't apply to checkpoint inhibitors because this is driven by the patient's immune system. So, unfortunately, particularly for higher toxicities, just stopping the ...